RT Journal Article SR Electronic T1 NICOTINIC AND MUSCARINIC RECEPTORS IN THE CARDIAC SYMPATHETIC GANGLIA OF THE DOG JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 106 OP 115 VO 168 IS 1 A1 JEROME H. FLEISCH A1 WERNER FLACKE A1 RICHARD A. GILLIS YR 1969 UL http://jpet.aspetjournals.org/content/168/1/106.abstract AB Evidence for the existence of muscarinic as well as nicotinic receptor sites was sought in experiments in open-chest spinal dogs. Acetylcholine was injected into the right subclavian artery to reach the sympathetic cardiac ganglia. Heart rate increase was used as indicator of ganglionic stimulation. Dose-response curves for i.a. acetyicholine vs heart rate were obtained. Hexamethonium (10-30 mg/kg) and other "nicotinic" antagonists (d-tubo curarine, mecamylamine and chlorisondamine) affected this curve very little and increased the maximally obtainable response. Atropine (0.01-3.0 mg/kg) and scopolamine caused a small shift to the right (dose ratio, about 3). Atropine, given in divided doses after a prior "loading" dose of hexamethonium or similar agent, caused dose-dependent shifts of the acetylcholine dose-response curves to the right (dose ratio with 0.1 mg/kg of atropine, about 20). Hexamethonium, after a prior loading dose of atropine, shifted the dose-response curve stepwise to the right (dose ratio with 10 mg/kg of hexamethonium, 5-10). This work confirms the presence of muscarinic receptors in cardiac sympathetic ganglia of the dog postulated previously on the basis of nerve stimulation experiments. © 1969, by The Williams & Wilkins Company